Accounts Payable, Accrued Expenses and Other

6 Months Ended

Jun. 30, 2015

6. Accounts Payable, Accrued Expenses and Other

Accounts payable, accrued expenses and other as of June 30, 2015 and December 31, 2014 consisted of the following:


(in thousands)	As of June 30, 2015		As of December 31, 2014
Accounts payable	$	6,783	$	2,510
Accrued goods and services		13,177		12,481
Accrued clinical trial costs		8,514		7,637
Accrued payroll and related benefits		3,866		6,166
Accrued interest		2,944		2,956
Accrued dividends payable		19		19
Accrued milestone payment owed to PharmaEngine		11,000		5,000
Deferred tax incentives		323		467

Total accounts payable, accrued expenses and other	$	46,626	$	37,236